ervices primarily to the health care industry, focusing on business strategy, operations, and general management issues. The Company provides best practices and research through discrete programs to a membership of approximately 2,800 organizations, including leading hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, colleges, universities, and other education institutions. Members of each program are typically charged a fixed annual fee and have access to an integrated set of services that may include best practice research studies, executive education seminars, customized research briefs, web-based access to the program's content database, and business intelligence tools.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on information available to the Company as of November 2, 2009, the date of this news release, as well as the Company's current projections, forecasts, and assumptions, and involve risks and uncertainties. You are hereby cautioned that these statements may be affected by certain factors, including those set forth below. Consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements, and reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ materially from those indicated by forward-looking statements include, among others, changes in the financial condition of the health care industry, our dependence on renewal of membership-based services, the need to attract new business and retain current members and qualified personnel, new product development, competition, risks associated with our business intelligence tools and installation support tools, our ability to license technology fr
'/>"/>
SOURCE The Advisory Board Company Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation2.
The Advisory Board Company Schedules Second Quarter Conference Call for November 2, 20093.
Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board4.
World-first mental health media initiative announces inaugural Advisory Group5.
Tranziger Announces Formation of Global Advisory & Development Team6.
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma7.
William Fuchs Named to PerfectServe Advisory Board8.
Data Strategy Invited to Become a Member of VMware's Partner Technical Advisory Board (PTAB)9.
Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First Modified Risk Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee10.
FDA Advisory Committee Unanimously Recommends Approval of XIAFLEX(TM) for Treatment of Dupuytrens Disease11.
Robert Fanning Named to PerfectServe Advisory Board